SLS Borrow Fee Update: 10.97% CTB

Borrow Fee Update: SLS

Sellas Life Sciences Group (SLS) is currently trading with a borrow fee of 10.97% according to Interactive Brokers data. As of September 6, 2026, there were approximately 35,000 shares available for borrowing. The borrow fee, or cost-to-borrow (CTB), is a critical metric for short sellers, and the current rate reflects the cost of maintaining short positions in the stock. Traders should note that the availability of shares is relatively low, which can lead to rapid spikes in borrow fees if demand for shorting increases. This data is updated every 15 minutes, providing a near-real-time view of the lending market for SLS.

Source

Signal data sourced from ChartExchange. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Lending Market Alert#US Equities

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets.

Commission a Report